JP2008516982A5 - - Google Patents

Download PDF

Info

Publication number
JP2008516982A5
JP2008516982A5 JP2007537010A JP2007537010A JP2008516982A5 JP 2008516982 A5 JP2008516982 A5 JP 2008516982A5 JP 2007537010 A JP2007537010 A JP 2007537010A JP 2007537010 A JP2007537010 A JP 2007537010A JP 2008516982 A5 JP2008516982 A5 JP 2008516982A5
Authority
JP
Japan
Prior art keywords
phenyl
aminopropyl
difluorophenyl
thiadiazol
fluorophenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007537010A
Other languages
English (en)
Japanese (ja)
Other versions
JP5128283B2 (ja
JP2008516982A (ja
Filing date
Publication date
Priority claimed from US11/252,232 external-priority patent/US7449486B2/en
Application filed filed Critical
Publication of JP2008516982A publication Critical patent/JP2008516982A/ja
Publication of JP2008516982A5 publication Critical patent/JP2008516982A5/ja
Application granted granted Critical
Publication of JP5128283B2 publication Critical patent/JP5128283B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2007537010A 2004-10-19 2005-10-18 有糸分裂キネシン阻害剤およびその使用方法 Expired - Lifetime JP5128283B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US62004804P 2004-10-19 2004-10-19
US60/620,048 2004-10-19
US11/252,232 US7449486B2 (en) 2004-10-19 2005-10-17 Mitotic kinesin inhibitors and methods of use thereof
US11/252,232 2005-10-17
PCT/US2005/037305 WO2006044825A2 (en) 2004-10-19 2005-10-18 Mitotic kinesin inhibitors and methods of use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012193218A Division JP5757666B2 (ja) 2004-10-19 2012-09-03 有糸分裂キネシン阻害剤およびその使用方法

Publications (3)

Publication Number Publication Date
JP2008516982A JP2008516982A (ja) 2008-05-22
JP2008516982A5 true JP2008516982A5 (https=) 2008-10-09
JP5128283B2 JP5128283B2 (ja) 2013-01-23

Family

ID=36203637

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2007537010A Expired - Lifetime JP5128283B2 (ja) 2004-10-19 2005-10-18 有糸分裂キネシン阻害剤およびその使用方法
JP2012193218A Expired - Fee Related JP5757666B2 (ja) 2004-10-19 2012-09-03 有糸分裂キネシン阻害剤およびその使用方法
JP2014094479A Expired - Fee Related JP5911909B2 (ja) 2004-10-19 2014-05-01 有糸分裂キネシン阻害剤およびその使用方法
JP2015079762A Pending JP2015129191A (ja) 2004-10-19 2015-04-09 有糸分裂キネシン阻害剤およびその使用方法

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2012193218A Expired - Fee Related JP5757666B2 (ja) 2004-10-19 2012-09-03 有糸分裂キネシン阻害剤およびその使用方法
JP2014094479A Expired - Fee Related JP5911909B2 (ja) 2004-10-19 2014-05-01 有糸分裂キネシン阻害剤およびその使用方法
JP2015079762A Pending JP2015129191A (ja) 2004-10-19 2015-04-09 有糸分裂キネシン阻害剤およびその使用方法

Country Status (26)

Country Link
US (8) US7449486B2 (https=)
EP (1) EP1809280B1 (https=)
JP (4) JP5128283B2 (https=)
KR (1) KR101280755B1 (https=)
CN (4) CN103626720B (https=)
AT (1) ATE523196T1 (https=)
AU (1) AU2005295403B2 (https=)
BR (1) BRPI0518228B8 (https=)
CA (4) CA2852516C (https=)
CY (1) CY1112238T1 (https=)
DK (1) DK1809280T3 (https=)
ES (1) ES2370774T3 (https=)
HR (1) HRP20110764T1 (https=)
IL (2) IL182417A0 (https=)
ME (1) ME01950B (https=)
MX (1) MX2007004547A (https=)
NO (1) NO341725B1 (https=)
NZ (1) NZ554306A (https=)
PL (1) PL1809280T3 (https=)
PT (1) PT1809280E (https=)
RS (1) RS52037B (https=)
RU (1) RU2426729C2 (https=)
SI (1) SI1809280T1 (https=)
TW (1) TWI357900B (https=)
WO (1) WO2006044825A2 (https=)
ZA (1) ZA200703168B (https=)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE480527T1 (de) * 2001-12-11 2010-09-15 Kyowa Hakko Kirin Co Ltd Thiadiazolinderivate zur krebsbehandlung
CA2522594C (en) 2003-04-18 2012-01-24 Kyowa Hakko Kogyo Co., Ltd. Mitotic kinesin inhibitor
US20070276017A1 (en) * 2003-06-10 2007-11-29 Chikara Murakata Thiadiazoline Derivative
CA2576057A1 (en) * 2004-08-18 2006-03-23 Merck & Co., Inc. Mitotic kinesin inhibitors
US7449486B2 (en) 2004-10-19 2008-11-11 Array Biopharma Inc. Mitotic kinesin inhibitors and methods of use thereof
EP1870404A4 (en) * 2005-03-22 2010-07-14 Kyowa Hakko Kirin Co Ltd MEANS FOR THE TREATMENT OF A HEMATOPOIETIC TUMOR
WO2006101102A1 (ja) * 2005-03-22 2006-09-28 Kyowa Hakko Kogyo Co., Ltd. 固形腫瘍治療剤
UA95907C2 (en) 2005-05-02 2011-09-26 Эррей Биофарма Инк. Mitotic kinesin inhibitors and methods of use thereof
EP1908755A4 (en) * 2005-06-24 2009-06-24 Kyowa Hakko Kirin Co Ltd THERAPEUTIC AGENT AGAINST RESTENOSIS
EP2081918A2 (en) * 2006-10-03 2009-07-29 Array Biopharma, Inc. Mitotic kinesin inhibitors and methods of use thereof
WO2008070739A1 (en) * 2006-12-06 2008-06-12 Cytokinetics, Inc. Ksp activators
AR068888A1 (es) * 2007-10-19 2009-12-16 Schering Corp Derivados de 1, 3, 4 - tiadiazol, una composicion farmaceutica que los comprende y su uso en la preparacion de medicamentos para el tratamiento de enfermedades mediadas por la inhibicion de la quinesina ksp.
CL2008003062A1 (es) * 2007-11-09 2010-02-19 Schering Corp Compuestos derivados de pirazoles espiro conjugados, inhibidores de la actividad de ksp kinesina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de enfermedades proliferativas.
CN104958292B (zh) * 2008-10-16 2018-10-16 阵列生物制药公司 用于在治疗中增加凋亡的有丝分裂抑制剂
US9561214B2 (en) * 2008-10-16 2017-02-07 Array Biopharma Inc. Method of treatment using inhibitors of mitosis
EP2430030A1 (en) * 2009-05-13 2012-03-21 Schering Corporation Spiro 1,3,4-thiadiazoline derivatives as ksp inhibitors
PT2544679T (pt) 2010-03-12 2019-07-11 Omeros Corp Inibidores de pde-10 e composições e métodos relacionados
FR2991199B1 (fr) * 2012-05-30 2015-05-15 IFP Energies Nouvelles Procede de preparation d'un catalyseur mettant en oeuvre une etape de sechage rapide et son utilisation pour la synthese fischer-tropsch
HK1206275A1 (en) 2012-08-13 2016-01-08 Array Biopharma, Inc. Arry-520 for use in treating cancer in a patient with low aag
AU2014227478A1 (en) 2013-08-08 2015-02-26 Array Biopharma Inc. Filanesib combined with pomalidomide displays enhanced anti-tumor activity
PL3086814T3 (pl) 2013-12-23 2020-12-28 Bayer Pharma Aktiengesellschaft Koniugaty środka wiążącego (ADC) z inhibitorami KSP
NZ716494A (en) * 2014-04-28 2017-07-28 Omeros Corp Processes and intermediates for the preparation of a pde10 inhibitor
NZ630803A (en) 2014-04-28 2016-03-31 Omeros Corp Optically active pde10 inhibitor
CN107635586B (zh) 2014-12-15 2021-09-24 拜耳医药股份有限公司 Ksp抑制剂与无糖基化抗-tweakr抗体的抗体-药物缀合物(adc)
US9879002B2 (en) 2015-04-24 2018-01-30 Omeros Corporation PDE10 inhibitors and related compositions and methods
RU2751512C2 (ru) 2015-06-22 2021-07-14 Байер Фарма Акциенгезельшафт Конъюгаты антитела и лекарственного средства (adc) и конъюгаты антитела и пролекарства (apdc), содержащие ферментативно расщепляемые группы
RU2018102358A (ru) 2015-06-23 2019-07-25 Байер Фарма Акциенгезельшафт Нацеленные конъюгаты ksp ингибиторов
WO2016207094A1 (de) 2015-06-23 2016-12-29 Bayer Pharma Aktiengesellschaft Antikörper-wirkstoff-konjugate (adcs) von ksp-inhibitoren mit anti-tweakr-antikörpern
US11071788B2 (en) 2015-06-23 2021-07-27 Bayer Pharma Aktiengesellschaft Antibody drug conjugates of kinesin spindel protein (KSP) inhibitors with antiB7H3-antibodies
US9920045B2 (en) 2015-11-04 2018-03-20 Omeros Corporation Solid state forms of a PDE10 inhibitor
WO2017216028A1 (en) 2016-06-15 2017-12-21 Bayer Pharma Aktiengesellschaft Specific antibody-drug-conjugates (adcs) with ksp inhibitors and anti-cd123-antibodies
JP7066714B2 (ja) 2016-12-21 2022-05-13 バイエル・ファルマ・アクティエンゲゼルシャフト 酵素的に切断可能な基を有する抗体薬物コンジュゲート（ａｄｃ）
JP7030811B2 (ja) 2016-12-21 2022-03-07 バイエル・ファルマ・アクティエンゲゼルシャフト Ｋｓｐ阻害剤を有する特異的抗体－薬物コンジュゲート（ａｄｃ）
JP2021527640A (ja) 2018-06-18 2021-10-14 バイエル アクチェンゲゼルシャフトＢａｙｅｒ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 酵素的に切断可能なリンカーおよび改善された活性プロファイルを有する、ｃｘｃｒ５に対して向けられるバインダー／活性薬剤複合体
AU2024265078A1 (en) 2023-05-04 2025-12-11 Revolution Medicines, Inc. Combination therapy for a ras related disease or disorder
IL326136A (en) 2023-08-07 2026-03-01 Revolution Medicines Inc RMC-6291 for use in the treatment of a disease or disorder associated with the RAS protein
US20250154171A1 (en) 2023-10-12 2025-05-15 Revolution Medicines, Inc. Ras inhibitors
WO2025096683A1 (en) * 2023-10-30 2025-05-08 University Of Health Sciences And Pharmacy In St. Louis Err modulators
WO2025096684A1 (en) * 2023-10-30 2025-05-08 University Of Health Sciences And Pharmacy In St. Louis Err modulators
WO2025171296A1 (en) 2024-02-09 2025-08-14 Revolution Medicines, Inc. Ras inhibitors
WO2025240847A1 (en) 2024-05-17 2025-11-20 Revolution Medicines, Inc. Ras inhibitors
US20250375445A1 (en) 2024-06-07 2025-12-11 Revolution Medicines, Inc. Methods of treating a ras protein-related disease or disorder
WO2025265060A1 (en) 2024-06-21 2025-12-26 Revolution Medicines, Inc. Therapeutic compositions and methods for managing treatment-related effects
WO2026006747A1 (en) 2024-06-28 2026-01-02 Revolution Medicines, Inc. Ras inhibitors
WO2026015796A1 (en) 2024-07-12 2026-01-15 Revolution Medicines, Inc. Methods of treating a ras related disease or disorder
WO2026015825A1 (en) 2024-07-12 2026-01-15 Revolution Medicines, Inc. Use of ras inhibitor for treating pancreatic cancer
WO2026015790A1 (en) 2024-07-12 2026-01-15 Revolution Medicines, Inc. Methods of treating a ras related disease or disorder
WO2026015801A1 (en) 2024-07-12 2026-01-15 Revolution Medicines, Inc. Methods of treating a ras related disease or disorder
WO2026050446A1 (en) 2024-08-29 2026-03-05 Revolution Medicines, Inc. Ras inhibitors
WO2026072904A2 (en) 2024-09-26 2026-04-02 Revolution Medicines, Inc. Compositions and methods for treating lung cancer

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2702803A (en) 1954-04-12 1955-02-22 Lilly Co Eli Substituted heterodiazoles
SU1065410A1 (ru) * 1982-05-07 1984-01-07 Днепропетровский Ордена Трудового Красного Знамени Химико-Технологический Институт Им.Ф.Э.Дзержинского Способ получени 2-амино-5-трет-алкил-1,3,4-тиадиазолов
ATE72431T1 (de) 1985-08-31 1992-02-15 Fisons Plc 5-gliedrige heterocyclische angiotensinumwandlungsenzym-inhibitoren.
US4762072A (en) * 1986-10-07 1988-08-09 Westinghouse Electric Corp. Desk and space dividing wall panel assembly
GB8625774D0 (en) 1986-10-28 1986-12-03 Reckitt & Colmann Prod Ltd Thiadiazole derivative
JPH0572686A (ja) 1991-09-11 1993-03-26 Konica Corp ハロゲン化銀写真感光材料
AU4288293A (en) 1992-04-27 1993-11-29 E.I. Du Pont De Nemours And Company Fungicidal 1,3,4-oxadiazines and 1,3,4-thiadiazines
US6159938A (en) 1994-11-21 2000-12-12 Cortech, Inc. Serine protease inhibitors comprising α-keto heterocycles
US5972937A (en) 1995-02-02 1999-10-26 Smithkline Beecham P.L.C. Heterocyclic compounds possessing 5HT2C receptor antagonist activity
US5958957A (en) 1996-04-19 1999-09-28 Novo Nordisk A/S Modulators of molecules with phosphotyrosine recognition units
US5668159A (en) 1996-05-08 1997-09-16 The Dupont Merck Pharmaceutical Company 1,3,4-thiadiazoles and 1,3,4-oxadiazoles as IIb/IIIa antagonists
AR011164A1 (es) 1997-02-28 2000-08-02 Lilly Co Eli Compuestos heterociclicos, composiciones farmaceuticas que los comprenden, y metodos para inhibir la liberacion del peptido beta-amiloide y/o su sintesismediante el uso de dichos compuestos
SI1045839T1 (en) 1997-12-16 2004-06-30 Warner-Lambert Company Llc Novel amines as pharmaceutical agents
JP2000159756A (ja) 1998-11-23 2000-06-13 American Cyanamid Co ２―アリ―ル―δ２―１，３，４―（オキサおよびチア）ジアゾリン殺虫および殺ダニ剤
US6235762B1 (en) 1998-11-23 2001-05-22 American Cyanamid Company 2-aryl-Δ2-1,3,4-(oxa and thia)diazoline insecticidal and acaricidal agents
HUP0105092A3 (en) * 1999-01-13 2003-12-29 Warner Lambert Co 1-heterocycle substituted diarylamines and medicaments containing them
US6380187B2 (en) 1999-03-25 2002-04-30 Dingwei Tim Yu Class of thiomorpholino substituted thiazoles
US6545004B1 (en) * 1999-10-27 2003-04-08 Cytokinetics, Inc. Methods and compositions utilizing quinazolinones
WO2001056994A1 (en) 2000-02-04 2001-08-09 Biogen, Inc. Integrin antagonists
US20040248950A1 (en) 2001-08-24 2004-12-09 Natsuki Ishizuka Apo ai expression accelerating agent
ATE480527T1 (de) 2001-12-11 2010-09-15 Kyowa Hakko Kirin Co Ltd Thiadiazolinderivate zur krebsbehandlung
EP1492487B1 (en) 2002-03-08 2009-11-11 Merck & Co., Inc. Mitotic kinesin inhibitors
WO2004002029A1 (de) 2002-06-25 2003-12-31 Andreas Gall Anordnung zur erfassung der nutzung von rds-rundfunkempfängern
US7294643B2 (en) * 2002-11-22 2007-11-13 Board Of Regents, The University Of Texas System UK-1 analogues: methods of preparation and use
US20050004186A1 (en) 2002-12-20 2005-01-06 Pfizer Inc MEK inhibiting compounds
US20040167188A1 (en) 2003-02-14 2004-08-26 Zhili Xin Protein-tyrosine phosphatase inhibitors and uses thereof
CA2522594C (en) 2003-04-18 2012-01-24 Kyowa Hakko Kogyo Co., Ltd. Mitotic kinesin inhibitor
US7326790B2 (en) 2003-05-02 2008-02-05 Rigel Pharmaceuticals, Inc. Diphenylisoxazole compounds and hydro isomers thereof
WO2004099164A1 (en) 2003-05-02 2004-11-18 Rigel Pharmaceuticals, Inc. Substituted diphenyl isoxazoles, pyrazoles and oxadiazoles useful for treating hcv infection
US20050075375A1 (en) 2003-05-14 2005-04-07 Anadys Pharmaceuticals, Inc. Heterocyclic compounds for treating hepatitis C virus
JP4847868B2 (ja) 2003-05-14 2011-12-28 ニューロジェネティック ファーマシューティカルズ、 インコーポレイテッド 化合物、及び、アミロイドベータの調節におけるその使用
US7220745B2 (en) 2003-05-15 2007-05-22 Rigel Pharmaceuticals Heterocyclic compounds useful to treat HCV
US20050009877A1 (en) 2003-05-15 2005-01-13 Henry Lu Methods of identifying HCV NS5B polymerase inhibitors and their uses
JPWO2004111023A1 (ja) 2003-06-10 2006-07-27 協和醗酵工業株式会社 チアジアゾリン−１−オキシド誘導体
US20070276017A1 (en) 2003-06-10 2007-11-29 Chikara Murakata Thiadiazoline Derivative
WO2005035512A1 (ja) 2003-10-10 2005-04-21 Kyowa Hakko Kogyo Co., Ltd. チアジアゾリン誘導体
JP2005232016A (ja) 2004-02-17 2005-09-02 Kyowa Hakko Kogyo Co Ltd オキサジアゾリン誘導体
GB0406867D0 (en) 2004-03-26 2004-04-28 F2G Ltd Antifungal agents
CA2576057A1 (en) 2004-08-18 2006-03-23 Merck & Co., Inc. Mitotic kinesin inhibitors
US7449486B2 (en) 2004-10-19 2008-11-11 Array Biopharma Inc. Mitotic kinesin inhibitors and methods of use thereof
FR2876586B1 (fr) 2004-10-20 2007-10-12 Persee Medica Composition pour prevenir ou traiter le stress, notamment les bouffees de stress chronique et permanent
WO2006101102A1 (ja) * 2005-03-22 2006-09-28 Kyowa Hakko Kogyo Co., Ltd. 固形腫瘍治療剤
EP1870404A4 (en) * 2005-03-22 2010-07-14 Kyowa Hakko Kirin Co Ltd MEANS FOR THE TREATMENT OF A HEMATOPOIETIC TUMOR
JP2008150291A (ja) * 2005-03-22 2008-07-03 Kyowa Hakko Kogyo Co Ltd 乾癬治療剤
JP2006265107A (ja) * 2005-03-22 2006-10-05 Kyowa Hakko Kogyo Co Ltd 緑内障治療剤
JP2008137893A (ja) * 2005-03-22 2008-06-19 Kyowa Hakko Kogyo Co Ltd 関節炎治療剤
UA95907C2 (en) 2005-05-02 2011-09-26 Эррей Биофарма Инк. Mitotic kinesin inhibitors and methods of use thereof
EP1908755A4 (en) * 2005-06-24 2009-06-24 Kyowa Hakko Kirin Co Ltd THERAPEUTIC AGENT AGAINST RESTENOSIS
EP2081918A2 (en) 2006-10-03 2009-07-29 Array Biopharma, Inc. Mitotic kinesin inhibitors and methods of use thereof
TWI411395B (zh) 2007-12-24 2013-10-11 Syngenta Participations Ag 殺蟲化合物
US9561214B2 (en) 2008-10-16 2017-02-07 Array Biopharma Inc. Method of treatment using inhibitors of mitosis
HK1206275A1 (en) 2012-08-13 2016-01-08 Array Biopharma, Inc. Arry-520 for use in treating cancer in a patient with low aag
AU2014227478A1 (en) 2013-08-08 2015-02-26 Array Biopharma Inc. Filanesib combined with pomalidomide displays enhanced anti-tumor activity

Similar Documents

Publication Publication Date Title
JP2008516982A5 (https=)
RU2007118632A (ru) Ингибиторы митотического кинезина и способы их использования
US10058534B2 (en) Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders
RU2506267C2 (ru) Бензопирановые и бензоксепиновые ингибиторы рi3k и их применение
JP2004513108A5 (https=)
JP2010524937A5 (https=)
JP2006517572A5 (https=)
JP2018512408A5 (https=)
RU2481330C2 (ru) Азотсодержащее ароматическое гетероциклическое соединение
JP2014526500A5 (https=)
JP2006506340A5 (https=)
RU2006109599A (ru) Гетероциклические ингибиторы мек и способы их применения
JP2011517457A5 (https=)
RU2007124545A (ru) Производные [4-(гетероарил)пиперазин-1-ил]-(2,5-замещенный фенил)метанона в качестве ингибиторов переносчика глицина-1 (glyt-1) для лечения неврологических и психоневрологических заболеваний
TW200823182A (en) Chemical compounds
JP2007510689A5 (https=)
WO2015092634A1 (en) 1,2,3,4-tetrahydroisoquinoline compounds and compositions as selective estrogen receptor antagonists and degraders
JP2021535112A5 (https=)
RU2017133983A (ru) Бициклические тетрагидротиазепиновые производные, полезные для лечения неопластических и/или инфекционных заболеваний
RU2011116232A (ru) Пиразолопиридиновые производные как ингибиторы надфн-оксидазы
JP2016525104A5 (https=)
RU2013130878A (ru) Гидроксилированные производные аминотриазола в качестве агонистов рецептора alx
JP2010519278A5 (https=)
WO2009019472A4 (en) 1, 2, 4 -triazole derivatives as serotonergic modulators
JP2008526818A5 (https=)